Eversept Partners, LP
Filing Date
Global Rank
#1,046
/ 8,232
▲ 58
Top Industry
Biotechnology
45.7%
3Y Alpha vs SPY
+1.3%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+81.9%
SPY
+76.3%
Annualised alpha
+1.3%
Max drawdown
−26.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
110 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
8.6%
+0.5 pts
Top 5
32.2%
−1.0 pts
Top 10
50.0%
+1.1 pts
HHI
345
Diversified+12
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 82.7% | $1,502,626,474 |
| Unclassified | 11.4% | $207,359,246 |
| Real Estate | 5.9% | $106,924,282 |
| Financial Services | 0.0% | $510,306 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BKD | Brookdale Senior Living Inc. | +3,193,626 | 3,568,555 | $48,817,832 | |
| GERN | Geron Corp | +1,174,900 | 18,834,883 | $28,063,975 | |
| BBNX | Beta Bionics, Inc. | +736,576 | 1,414,838 | $14,176,676 | |
| CYH | Community Health Systems Inc | +733,479 | 8,677,281 | $25,511,206 | |
| CTMX | CytomX Therapeutics, Inc. | +681,424 | 3,188,514 | $14,986,015 | |
| ARDX | Ardelyx, Inc. | +514,317 | 2,229,446 | $13,354,381 | |
| CLDX | Celldex Therapeutics, Inc. | +353,291 | 1,788,016 | $56,715,867 | |
| ALEC | Alector, Inc. | +344,943 | 1,351,106 | $2,904,877 | |
| ABVX | Abivax S.A. | +276,589 | 934,423 | $104,048,001 | |
| SVRA | Savara Inc | +214,069 | 384,264 | $2,098,081 | |
| LQDA | Liquidia Corp | +167,949 | 677,392 | $25,564,774 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +141,946 | 576,580 | $13,584,224 | |
| IVVD | Invivyd, Inc. | +136,219 | 2,276,349 | $2,959,253 | |
| BMRN | Biomarin Pharmaceutical Inc | +114,020 | 207,768 | $11,736,814 | |
| IONS | Ionis Pharmaceuticals Inc | +93,882 | 632,100 | $47,464,389 | |
| EHC | Encompass Health Corp | +87,178 | 194,104 | $18,775,679 | |
| PODD | Insulet Corp | +68,838 | 143,546 | $30,121,692 | |
| SPY | Spdr S&P 500 ETF Trust | +62,100 | 107,000 | $69,586,380 | |
| ENGN | enGene Therapeutics Inc. | +54,708 | 510,543 | $3,476,797 | |
| NTRA | Natera, Inc. | +50,220 | 384,713 | $76,938,752 | |
| PLRX | Pliant Therapeutics, Inc. | +49,402 | 891,425 | $1,123,195 | |
| BCRX | Biocryst Pharmaceuticals Inc | +46,925 | 3,039,820 | $28,939,086 | |
| WHWK | Whitehawk Therapeutics, Inc. | +46,541 | 306,800 | $1,058,460 | |
| SSII | SS Innovations International, Inc. | +34,799 | 110,157 | $550,785 | |
| PNTG | Pennant Group, Inc. | +18,218 | 312,178 | $9,515,185 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | −2,115,170 | 1,735,963 | $4,756,538 | |
| VRDN | Viridian Therapeutics, Inc.DE | −1,068,966 | 713,269 | $13,951,541 | |
| VERA | Vera Therapeutics, Inc. | −899,018 | 2,173,286 | $87,431,295 | |
| GSK | GSK plc | −894,546 | 1,785,175 | $98,523,808 | |
| BRKR | Bruker Corp | −666,776 | 117,013 | $4,226,509 | |
| TVTX | Travere Therapeutics, Inc. | −632,358 | 542,610 | $16,120,943 | |
| SNDX | Syndax Pharmaceuticals Inc | −428,786 | 2,885,622 | $67,408,129 | |
| PALI | Palisade Bio, Inc. | −404,049 | 4,987,499 | $8,728,123 | |
| BVS | Bioventus Inc. | −312,147 | 159,110 | $1,452,674 | |
| PCVX | Vaxcyte, Inc. | −273,529 | 924,193 | $53,704,855 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −254,607 | 62,575 | $1,310,946 | |
| TECH | BIO-TECHNE Corp | −251,509 | 125,896 | $6,579,324 | |
| TYRA | Tyra Biosciences, Inc. | −251,509 | 27,055 | $1,036,206 | |
| RLAY | Relay Therapeutics, Inc. | −218,432 | 270,705 | $2,693,514 | |
| CNC | Centene Corp | −212,440 | 111,652 | $3,655,486 | |
| AVTR | Avantor, Inc. | −202,357 | 2,974,287 | $23,318,410 | |
| NAMS | NewAmsterdam Pharma Co N.V. | −135,063 | 285,764 | $9,147,305 | |
| HQY | Healthequity, Inc. | −134,125 | 51,614 | $4,313,381 | |
| STRO | Sutro Biopharma, Inc. | −120,410 | 73,161 | $1,822,440 | |
| ASMB | Assembly Biosciences, Inc. | −118,787 | 40,889 | $1,134,669 | |
| SPRY | ARS Pharmaceuticals, Inc. | −115,358 | 136,235 | $1,093,967 | |
| MRNA | Moderna, Inc. | −108,115 | 159,708 | $8,113,166 | |
| XENE | Xenon Pharmaceuticals Inc. | −101,806 | 129,574 | $7,534,728 | |
| AVR | Anteris Technologies Global Corp. | −98,813 | 401,187 | $2,226,587 | |
| ANAB | Anaptysbio, Inc | −93,838 | 27,089 | $1,502,355 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QGEN | Qiagen N.V. | 1,021,630 | $40,906,065 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | 90,000 | $40,188,600 | |
| WELL | Welltower Inc. | 180,953 | $35,776,217 | |
| DOC | Healthpeak Properties, Inc. | 1,981,070 | $32,548,980 | |
| OHI | Omega Healthcare Investors Inc | 585,680 | $25,664,497 | |
| INSM | INSMED Inc | 94,000 | $15,370,880 | |
| RGEN | Repligen Corp | 120,785 | $14,230,888 | |
| LTC | Ltc Properties Inc | 321,046 | $11,930,069 | |
| CHE | Chemed Corp | 31,057 | $11,731,471 | |
| VKTX | Viking Therapeutics, Inc. | 239,110 | $7,780,639 | |
| AGIO | Agios Pharmaceuticals, Inc. | 200,000 | $6,766,000 | |
| THC | Tenet Healthcare Corp | 29,512 | $5,569,209 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 10,000 | $5,234,700 | |
| PRAX | Praxis Precision Medicines, Inc. | 14,800 | $4,768,412 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 183,902 | $3,942,858 | |
| CMPS | COMPASS Pathways plc | 677,924 | $3,748,919 | |
| GRCE | Grace Therapeutics, Inc. | 756,600 | $3,503,058 | |
| UHS | Universal Health Services Inc | 18,200 | $3,257,254 | |
| DFTX | Definium Therapeutics, Inc. | 160,723 | $3,037,664 | |
| EQ | Equillium, Inc. | 1,498,993 | $2,997,986 | |
| ENSG | Ensign Group, Inc | 14,761 | $2,974,341 | |
| REPL | Replimune Group, Inc. | 386,861 | $2,959,486 | |
| PMVP | PMV Pharmaceuticals, Inc. | 2,348,360 | $2,911,966 | |
| ANRO | Alto Neuroscience, Inc. | 125,168 | $2,813,776 | |
| LBRX | Lb Pharmaceuticals Inc | 100,198 | $2,470,882 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| DHR | Danaher Corp /De/ | 186,262 | $42,639,097 | |
| EXAS | EXACT SCIENCES CORP | 241,678 | $24,544,817 | |
| TEVA | Teva Pharmaceutical Industries Ltd | 660,177 | $20,604,124 | |
| BIIB | Biogen Inc. | 77,944 | $13,717,364 | |
| SEM | Select Medical Holdings Corp | 906,100 | $13,455,585 | |
| CGON | CG Oncology, Inc. | 308,466 | $12,807,508 | |
| BMY | Bristol Myers Squibb Co | 235,293 | $12,691,704 | |
| ELV | Elevance Health, Inc. | 30,195 | $10,584,857 | |
| MNKD | Mannkind Corp | 1,852,563 | $10,504,032 | |
| ASND | Ascendis Pharma A/S | 48,241 | $10,286,910 | |
| ILMN | Illumina, Inc. | 76,721 | $10,062,726 | |
| EWTX | Edgewise Therapeutics, Inc. | 337,340 | $8,371,092 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 358,168 | $8,359,641 | |
| HUM | Humana Inc | 32,462 | $8,314,492 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 10,097 | $7,793,571 | |
| CVS | CVS HEALTH Corp | 63,696 | $5,054,914 | |
| ACAD | Acadia Pharmaceuticals Inc | 176,594 | $4,716,825 | |
| PTGX | Protagonist Therapeutics, Inc | 52,961 | $4,625,613 | |
| ZBIO | Zenas BioPharma, Inc. | 121,016 | $4,394,090 | |
| NHC | National Healthcare Corp | 28,577 | $3,917,620 | |
| FTRE | Fortrea Holdings Inc. | 224,139 | $3,866,397 | |
| MRVI | Maravai Lifesciences Holdings, Inc. | 718,582 | $2,335,391 | |
| EOLS | Evolus, Inc. | 344,104 | $2,288,291 | |
| RAPP | Rapport Therapeutics, Inc. | 59,233 | $1,797,129 | |
| BHVN | Biohaven Ltd. | 145,431 | $1,641,915 | |
| No positions match the current search. | ||||
110 positions ·
$1,817,420,308 total
· as of Mar 31, 2026
Showing 1–50
of 110 positions by value
· page 1 of 3
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 264,271 | $156,707,417 | 8.62% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
Added | 238,700 | $137,772,866 | 7.58% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 934,423 | $104,048,001 | 5.73% | |
| GSK |
GSK plc
Healthcare
|
Reduced | 1,785,175 | $98,523,808 | 5.42% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 2,173,286 | $87,431,295 | 4.81% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 384,713 | $76,938,752 | 4.23% | |
| SPY |
Spdr S&P 500 ETF Trust
|
Added | 107,000 | $69,586,380 | 3.83% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 2,885,622 | $67,408,129 | 3.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 1,788,016 | $56,715,867 | 3.12% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 924,193 | $53,704,855 | 2.96% | |
| BKD |
Brookdale Senior Living Inc.
Healthcare
|
Added | 3,568,555 | $48,817,832 | 2.69% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 632,100 | $47,464,389 | 2.61% | |
| QGEN |
Qiagen N.V.
Healthcare
|
NEW | 1,021,630 | $40,906,065 | 2.25% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
NEW | 90,000 | $40,188,600 | 2.21% | |
| HCA |
HCA Healthcare, Inc.
Healthcare
|
Reduced | 79,229 | $37,494,331 | 2.06% | |
| WELL |
Welltower Inc.
Real Estate
|
NEW | 180,953 | $35,776,217 | 1.97% | |
| DOC |
Healthpeak Properties, Inc.
Real Estate
|
NEW | 1,981,070 | $32,548,980 | 1.79% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 143,546 | $30,121,692 | 1.66% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 3,039,820 | $28,939,086 | 1.59% | |
| GERN |
Geron Corp
Healthcare
|
Added | 18,834,883 | $28,063,975 | 1.54% | |
| OHI |
Omega Healthcare Investors Inc
Real Estate
|
NEW | 585,680 | $25,664,497 | 1.41% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 677,392 | $25,564,774 | 1.41% | |
| CYH |
Community Health Systems Inc
Healthcare
|
Reduced | 8,677,281 | $25,511,206 | 1.40% | |
| AVTR |
Avantor, Inc.
Healthcare
|
Reduced | 2,974,287 | $23,318,410 | 1.28% | |
| EHC |
Encompass Health Corp
Healthcare
|
Added | 194,104 | $18,775,679 | 1.03% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 19,000 | $17,475,630 | 0.96% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 542,610 | $16,120,943 | 0.89% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 94,000 | $15,370,880 | 0.85% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 3,188,514 | $14,986,015 | 0.82% | |
| RGEN |
Repligen Corp
Healthcare
|
NEW | 120,785 | $14,230,888 | 0.78% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Added | 1,414,838 | $14,176,676 | 0.78% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 713,269 | $13,951,541 | 0.77% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 576,580 | $13,584,224 | 0.75% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Added | 2,229,446 | $13,354,381 | 0.73% | |
| LTC |
Ltc Properties Inc
Real Estate
|
NEW | 321,046 | $11,930,069 | 0.66% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 207,768 | $11,736,814 | 0.65% | |
| CHE |
Chemed Corp
Healthcare
|
NEW | 31,057 | $11,731,471 | 0.65% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 406,960 | $11,496,620 | 0.63% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Reduced | 40,000 | $10,823,600 | 0.60% | |
| PNTG |
Pennant Group, Inc.
Healthcare
|
Added | 312,178 | $9,515,185 | 0.52% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 285,764 | $9,147,305 | 0.50% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Reduced | 4,987,499 | $8,728,123 | 0.48% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Reduced | 159,708 | $8,113,166 | 0.45% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
NEW | 239,110 | $7,780,639 | 0.43% | |
| ICLR |
Icon PLC
Healthcare
|
Reduced | 68,688 | $7,601,014 | 0.42% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 129,574 | $7,534,728 | 0.41% | |
| RVTY |
Revvity, Inc.
Healthcare
|
Reduced | 84,854 | $7,434,058 | 0.41% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
NEW | 200,000 | $6,766,000 | 0.37% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 138,036 | $6,653,335 | 0.37% | |
| TECH |
BIO-TECHNE Corp
Healthcare
|
Reduced | 125,896 | $6,579,324 | 0.36% |